OMED - Oncomed Pharmaceuticals Inc - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - OMED (1302573)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
36 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m
P2+8+10+34-42
S34-4-6-16-31

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Share Price

Shares Traded

Shares Owned

Own chg

Value Traded

1d ret

1w ret

1m ret

6m ret

D
2017-03-15
OMEDHager Alicia J.SVP, GCS - Sale+OE$10.00-6,65225,877-20%-$66,520-3-8
DM
2017-01-05
OMEDHastings Paul JCOB, CEOS - Sale+OE$8.34-42,738362,163-11%-$356,559+1-8-9
D
2017-01-03
OMEDLewicki John A.EVP, Research, DevelopmentS - Sale+OE$7.63-9,175116,451-7%-$70,045+5-2-1
D
2017-01-03
OMEDHoey TimothySVP, Cancer Biology, Co-CSOS - Sale+OE$7.64-12,76360,979-17%-$97,448+5-2-1
D
2016-11-16
OMEDHoey TimothySVP, Cancer Biology, Co-CSOS - Sale+OE$9.89-12,50060,979-17%-$123,609-2-1-20
D
2016-01-11
OMEDDupont JakobSVP, Chief Medical OfficerS - Sale+OE$20.01-2,50020,642-11%-$50,021-13-10-47-24
M
2016-01-06
OMEDDupont JakobSVP, Chief Medical OfficerS - Sale$22.28-2,16220,642-9%-$48,160-15-21-52-35
M
2016-01-06
OMEDGurney AustinSee RemarksS - Sale$22.28-2,16233,257-6%-$48,160-15-21-52-35
M
2016-01-06
OMEDHoey TimothySVP, Cancer BiologyS - Sale$22.28-2,16247,181-4%-$48,162-15-21-52-35
2016-01-06
OMEDHastings Paul JCOB, CEOS - Sale$22.28-2,412346,865-1%-$53,731-15-21-52-35
M
2016-01-06
OMEDHager Alicia J.VP, GCS - Sale$22.28-1,62313,377-11%-$36,153-15-21-52-35
M
2016-01-06
OMEDPatel SunilSee RemarksS - Sale$22.28-2,16217,838-11%-$48,168-15-21-52-35
M
2016-01-06
OMEDLewicki John A.EVP, Chief Scientific OfficerS - Sale$22.28-2,162102,653-2%-$48,162-15-21-52-35
D
2015-12-10
OMEDDupont JakobSVP, Chief Medical OfficerS - Sale+OE$20.49-2,50022,804-10%-$51,231+3+3-25-39
D
2015-11-27
OMEDHager Alicia J.VP, GCS - Sale+OE$23.14-1,80015,000-11%-$41,654-6-4+4-28
D
2015-11-10
OMEDDupont JakobSVP, Chief Medical OfficerS - Sale+OE$21.17-2,50022,804-10%-$52,923+3+12+1-41
D
2015-10-27
OMEDHager Alicia J.VP, GCS - Sale+OE$21.00-5,40015,000-26%-$113,400-8-2+9-42
2015-10-26
OMEDGurney AustinSee RemarksS - Sale$20.00-14,00035,419-28%-$280,000+2-2+5-49
D
2015-10-26
OMEDDupont JakobSVP, Chief Medical OfficerS - Sale+OE$20.00-5,00022,804-18%-$100,000+2-2+5-49
2015-09-30
OMEDLasersohn Jack WDirP - Purchase$16.01+11,2102,299,2670%+$179,512+13+9+29-40
M
2015-09-28
OMEDLasersohn Jack WDirP - Purchase$14.60+13,1402,288,057+1%+$191,784+2+10+38-44
D
2015-08-10
OMEDDupont JakobSVP, Chief Medical OfficerS - Sale+OE$22.25-2,50022,377-10%-$55,622-1+4-10-58
M
2015-07-29
OMEDGurney AustinSee RemarksS - Sale$20.88-14,00049,419-22%-$292,359-3-6-12-63
D
2015-07-28
OMEDHager Alicia J.VP, GCS - Sale+OE$21.00-1,80015,000-11%-$37,800+5+10-7-53
D
2015-07-10
OMEDDupont JakobSVP, Chief Medical OfficerS - Sale+OE$20.13-2,50022,377-10%-$50,325+3+2+6-3
D
2015-07-06
OMEDDupont JakobSVP, Chief Medical OfficerS - Sale+OE$21.22-2,50022,377-10%-$53,050-7-1+7+3
D
2015-06-29
OMEDHager Alicia J.VP, GCS - Sale+OE$22.67-1,80015,000-11%-$40,798-4-5-8-2
D
2015-06-22
OMEDHoey TimothySVP, Cancer BiologyS - Sale+OE$26.07-5,00049,343-9%-$130,337-4-8-12-13
DM
2015-06-15
OMEDLewicki John A.EVP, Chief Scientific OfficerS - Sale+OE$25.07-17,000104,815-14%-$426,125+20-16-22
D
2015-05-27
OMEDHager Alicia J.VP, GCS - Sale+OE$23.07-1,80015,000-11%-$41,527+3+2-2-7
2015-05-18
OMEDGurney AustinSee RemarksS - Sale$22.48-4,00063,419-6%-$89,9000+3+13-11
D
2015-04-27
OMEDHager Alicia J.VP, GCS - Sale+OE$25.65-1,80015,000-11%-$46,172-7-11-6-22
D
2015-04-27
OMEDHoey TimothySVP, Cancer BiologyS - Sale+OE$25.65-6,88749,343-12%-$176,645-7-11-6-22
2015-04-17
OMEDGurney AustinSee RemarksS - Sale$25.51-4,00067,419-6%-$102,049-4-4-16-31
D
2015-04-10
OMEDDupont JakobSVP, Chief Medical OfficerS - Sale+OE$26.51-1,50022,377-6%-$39,765+2+2-13-30
DM
2015-04-01
OMEDLewicki John A.EVP, Chief Scientific OfficerS - Sale+OE$25.28-17,000104,815-14%-$429,709-2+3-7-34

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top